Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Griffith

Showing results (531-540 of 565) with videos related to

Pageof 57
Sort By:
Cell Reports|March 13, 2021
The effect of spike mutations on SARS-CoV-2 neutralizationChloe Rees-Spear, Luke Muir, Sarah A Griffith, et al.
Journal of Medicinal Chemistry|April 4, 2015
Short Hydrophobic Peptides with Cyclic Constraints Are Potent Glucagon-like Peptide-1 Receptor (GLP-1R) AgonistsHuy N Hoang, Kun Song, Timothy A Hill, et al.
JCI Insight|May 6, 2020
Phase II clinical trial of metformin as a cancer stem cell-targeting agent in ovarian cancerJason R Brown, Daniel K Chan, Jessica J Shank, et al.
AIDS Research and Treatment|March 20, 2015
Ascertainment and verification of end-stage renal disease and end-stage liver disease in the north american AIDS cohort collaboration on research and designMari M Kitahata, Daniel R Drozd, Heidi M Crane, et al.
Journal of Veterinary Emergency and Critical Care (San Antonio, Tex. : 2001)|February 10, 2026
Multicenter Retrospective Cohort Study Evaluating the Efficacy of Extracorporeal Therapies Versus Medical Therapy for the Treatment of Severe Baclofen Intoxication in DogsNolan Vincent Chalifoux, Darko Stefanovski, Emmanuelle M Butty, et al.
Science (New York, N.Y.)|October 22, 2005
The evolution of Titan's mid-latitude cloudsC A Griffith, P Penteado, K Baines, et al.
Bioorganic & Medicinal Chemistry Letters|November 3, 2005
New bicyclic cannabinoid receptor-1 (CB1-R) antagonistsPhilip A Carpino, David A Griffith, Subas Sakya, et al.
Blood|May 21, 2011
Lenalidomide, bortezomib, pegylated liposomal doxorubicin, and dexamethasone in newly diagnosed multiple myeloma: a phase 1/2 Multiple Myeloma Research Consortium trialAndrzej J Jakubowiak, Kent A Griffith, Donna E Reece, et al.
Chemical Research in Toxicology|May 29, 2010
Discovery tactics to mitigate toxicity risks due to reactive metabolite formation with 2-(2-hydroxyaryl)-5-(trifluoromethyl)pyrido[4,3-d]pyrimidin-4(3h)-one derivatives, potent calcium-sensing receptor antagonists and clinical candidate(s) for the treatment of osteoporosisAmit S Kalgutkar, David A Griffith, Tim Ryder, et al.
Journal of Medicinal Chemistry|August 29, 2013
Spirolactam-based acetyl-CoA carboxylase inhibitors: toward improved metabolic stability of a chromanone lead structureDavid A Griffith, Robert L Dow, Kim Huard, et al.
Pageof 57

Showing results (531-540 of 565) with videos related to

Sort By:
Pageof 57
Cell Reports|March 13, 2021
The effect of spike mutations on SARS-CoV-2 neutralizationChloe Rees-Spear, Luke Muir, Sarah A Griffith, et al.
Journal of Medicinal Chemistry|April 4, 2015
Short Hydrophobic Peptides with Cyclic Constraints Are Potent Glucagon-like Peptide-1 Receptor (GLP-1R) AgonistsHuy N Hoang, Kun Song, Timothy A Hill, et al.
JCI Insight|May 6, 2020
Phase II clinical trial of metformin as a cancer stem cell-targeting agent in ovarian cancerJason R Brown, Daniel K Chan, Jessica J Shank, et al.
AIDS Research and Treatment|March 20, 2015
Ascertainment and verification of end-stage renal disease and end-stage liver disease in the north american AIDS cohort collaboration on research and designMari M Kitahata, Daniel R Drozd, Heidi M Crane, et al.
Journal of Veterinary Emergency and Critical Care (San Antonio, Tex. : 2001)|February 10, 2026
Multicenter Retrospective Cohort Study Evaluating the Efficacy of Extracorporeal Therapies Versus Medical Therapy for the Treatment of Severe Baclofen Intoxication in DogsNolan Vincent Chalifoux, Darko Stefanovski, Emmanuelle M Butty, et al.
Science (New York, N.Y.)|October 22, 2005
The evolution of Titan's mid-latitude cloudsC A Griffith, P Penteado, K Baines, et al.
Bioorganic & Medicinal Chemistry Letters|November 3, 2005
New bicyclic cannabinoid receptor-1 (CB1-R) antagonistsPhilip A Carpino, David A Griffith, Subas Sakya, et al.
Blood|May 21, 2011
Lenalidomide, bortezomib, pegylated liposomal doxorubicin, and dexamethasone in newly diagnosed multiple myeloma: a phase 1/2 Multiple Myeloma Research Consortium trialAndrzej J Jakubowiak, Kent A Griffith, Donna E Reece, et al.
Chemical Research in Toxicology|May 29, 2010
Discovery tactics to mitigate toxicity risks due to reactive metabolite formation with 2-(2-hydroxyaryl)-5-(trifluoromethyl)pyrido[4,3-d]pyrimidin-4(3h)-one derivatives, potent calcium-sensing receptor antagonists and clinical candidate(s) for the treatment of osteoporosisAmit S Kalgutkar, David A Griffith, Tim Ryder, et al.
Journal of Medicinal Chemistry|August 29, 2013
Spirolactam-based acetyl-CoA carboxylase inhibitors: toward improved metabolic stability of a chromanone lead structureDavid A Griffith, Robert L Dow, Kim Huard, et al.
Pageof 57